Publicaciones en las que colabora con José Miguel Escandell Planells (4)

2010

  1. Inhibition of delayed-type hypersensitivity by cucurbitacin R through the curbing of lymphocyte proliferation and cytokine expression by means of nuclear factor AT translocation to the nucleus

    Journal of Pharmacology and Experimental Therapeutics, Vol. 332, Núm. 2, pp. 352-363

2007

  1. Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in Lewis rats by suppression of tumor necrosis factor-α in T lymphocytes and macrophages

    Journal of Pharmacology and Experimental Therapeutics, Vol. 320, Núm. 2, pp. 581-590

  2. Dihydrocucurbitacin B inhibits delayed type hypersensitivity reactions by suppressing lymphocyte proliferation

    Journal of Pharmacology and Experimental Therapeutics, Vol. 322, Núm. 3, pp. 1261-1268

2006

  1. Dihydrocucurbitacin B, isolated from Cayaponia tayuya, reduces damage in adjuvant-induced arthritis

    European Journal of Pharmacology, Vol. 532, Núm. 1-2, pp. 145-154